WuXi AppTec Receives CLIA Certification for its Genomics Clinical Laboratory

We are delighted to announce that WuXi's genomics clinical laboratory inShanghai has successfully passed the survey by theCenters for Medicare and Medicaid Services of theU.S. Department of Health and Human Services relating...

WuXi Employees Honored at ACS National Meeting

The global chemistry community met in Indiana this month for the 246th ACS National Meeting and Exposition. WuXi was at the event, and we had much to celebrate, with two of...

Dr. James Pusey Named President and General Manager of WuXiPRA

WuXiPRA, a joint venture formed between WuXi and PRA, that offers  Phase I-IV clinical trial services in China, Hong Kong, and Macau, has recently  named Dr. James Pusey as president and...

WuXi Webinar “Demystifying Product Development in China” Attracts Big Audience

We held the complimentary webinar to offer insights into working in China, an operating environment that has remained a mystery to many despite its status as one of the industry’s most...

WuXi PharmaTech Corporate Venture Fund Participates in Syros $30M Series A

Syros Pharmaceuticals, a new startup company based in greater Boston area, raised $30 million funding in April 2013, which was led by ARCH Venture Partners and Flagship Ventures. Syros will use...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Inside Perspectives: Gene Editing Takes Center Stage

Depending on the scientific expert, gene editing is just another sophisticated gene therapy tool in the fight against human diseases or a technological advance...